<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Korde A</submitter><funding>U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI)</funding><funding>NHLBI NIH HHS</funding><funding>U.S. Department of Defense (United States Department of Defense)</funding><pagination>511</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11953391</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>Cigarette smoke (CS) creates a "cancer field" in the lung that promotes malignant transformation. The molecular changes within this field are not fully characterized. We examined the significance of microRNA-1 (miR-1) downregulation as one of these changes. We found that tumor miR-1 levels in three non-small cell lung cancer cohorts show inverse correlations with the smoking burden. Lung MiR-1 levels follow a spatial gradient, have prognostic significance, and correlate inversely with the molecular markers of injury. In CS-exposed lungs, miR-1 is specifically downregulated in the endothelium. Exposure to CS induces angiogenesis by selectively degrading mature miR-1 via a vascular endothelial growth factor-driven pathway. Applying a multi-step molecular screen, we identified angiogenic gene</pubmed_abstract><journal>Communications biology</journal><pubmed_title>Cigarette smoke induces angiogenic activation in the cancer field through dysregulation of an endothelial microRNA.</pubmed_title><pmcid>PMC11953391</pmcid><funding_grant_id>R01 HL155948</funding_grant_id><funding_grant_id>R01CA225977</funding_grant_id><funding_grant_id>R00 HL098695</funding_grant_id><funding_grant_id>PR211314</funding_grant_id><pubmed_authors>Diao L</pubmed_authors><pubmed_authors>Korde A</pubmed_authors><pubmed_authors>Zhang JG</pubmed_authors><pubmed_authors>Anderson S</pubmed_authors><pubmed_authors>Boffa DJ</pubmed_authors><pubmed_authors>Hu B</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Yan X</pubmed_authors><pubmed_authors>Moghaddam SJ</pubmed_authors><pubmed_authors>Velasco WV</pubmed_authors><pubmed_authors>Puchalski JT</pubmed_authors><pubmed_authors>Takyar SS</pubmed_authors><pubmed_authors>Ramaswamy A</pubmed_authors><pubmed_authors>Sauler M</pubmed_authors><pubmed_authors>Pisani MA</pubmed_authors><pubmed_authors>Jin L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cigarette smoke induces angiogenic activation in the cancer field through dysregulation of an endothelial microRNA.</name><description>Cigarette smoke (CS) creates a "cancer field" in the lung that promotes malignant transformation. The molecular changes within this field are not fully characterized. We examined the significance of microRNA-1 (miR-1) downregulation as one of these changes. We found that tumor miR-1 levels in three non-small cell lung cancer cohorts show inverse correlations with the smoking burden. Lung MiR-1 levels follow a spatial gradient, have prognostic significance, and correlate inversely with the molecular markers of injury. In CS-exposed lungs, miR-1 is specifically downregulated in the endothelium. Exposure to CS induces angiogenesis by selectively degrading mature miR-1 via a vascular endothelial growth factor-driven pathway. Applying a multi-step molecular screen, we identified angiogenic gene</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-02T20:38:20.311Z</modification><creation>2025-06-25T03:04:39.015Z</creation></dates><accession>S-EPMC11953391</accession><cross_references><pubmed>40155749</pubmed><doi>10.1038/s42003-025-07710-y</doi></cross_references></HashMap>